Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 64 Neoplasms 60 Prostatic Neoplasms 45 Colorectal Neoplasms 37 Lung Neoplasms 34 Carcinoma, Non-Small-Cell Lung 24 Hematologic Neoplasms 20 Neoplasm Metastasis 18 Head and Neck Neoplasms 18 Pancreatic Neoplasms 16 Multiple Myeloma 15 Urinary Bladder Neoplasms 14 Ovarian Neoplasms 12 Motor Activity 11 Leukemia, Myeloid, Acute 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 8 Hematopoietic and Lymphatic System Neoplasm 8 Glioblastoma 8 Gastrointestinal Neoplasms 8 Anxiety Disorders 8 Triple Negative Breast Neoplasms 7 Glioma 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Renal Cell 7 COVID-19 7 Uterine Cervical Neoplasms 6 Sarcoma 6

Interventions

lutetium Lu 177 dotatate 39 Everolimus 31 Magnetic Resonance Spectroscopy 15 lanreotide 13 gallium Ga 68 dotatate 12 Octreotide 12 Temozolomide 11 Capecitabine 11 Nivolumab 10 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 surufatinib 9 pembrolizumab 8 cabozantinib 8 Positron Emission Tomography Computed Tomography 8 3-Iodobenzylguanidine 8 Sunitinib 7 Specimen Handling 7 amino-acid, glucose, and electrolyte solution 6 Somatostatin 6 Lutetium-177 6 90Y-octreotide, DOTA-Tyr(3)- 6 telotristat ethyl 5 pasireotide 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Carboplatin 5 Bevacizumab 5 olaparib 4 copper dotatate CU-64 4 avelumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02472678 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡